Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ ForSight Vision5, Inc.
ForSight Vision5, Inc.
Industry · 8 registered clinical trials.
Status
Trial
Phase
Started
Completed
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle G
Open-Angle Glaucoma, Ocular Hypertension
Phase 1 / Phase 2
2016-04-30
Completed
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
Primary Open-Angle Glaucoma, Ocular Hypertension
Phase 2
2015-08-10
Completed
Bimatoprost Ocular Insert Pharmacokinetic Study
Healthy Volunteers
Phase 1
2015-03-01
Completed
Dose-Ranging Study of the Bimatoprost Ocular Insert
Primary Open-Angle Glaucoma, Ocular Hypertension
Phase 2
2015-01-19
Completed
Survey of Patients Taking IOP-Lowering Eye Drops
Glaucoma, Ocular Hypertension
—
2015-01-01
Completed
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
Primary Open-Angle Glaucoma, Ocular Hypertension
Phase 2
2014-06-05
Completed
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertensio
Primary Open-Angle Glaucoma, Ocular Hypertension
Phase 2
2013-10-23
Completed
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
Ocular Hypertension, Primary Open Angle Glaucoma
Phase 1
2013-10-01